Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review)
- PMID: 22076306
- DOI: 10.3892/ijo.2011.1248
Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review)
Abstract
In some inflammasomes tumor cells are generated. The internal environment of the inflammasome is conducive to the induction of malignant transformation. Epigenetic changes initiate this process. The subverted stromal connective tissue cells act to promote and sustain the process of malignant trans-formation. In its early stages, the premalignant cells depend on paracrine circuitries for the reception of growth factors. The ligands are derived from the connective tissue, and the receptors are expressed on the recipient premalignant cells. The initial events are not a direct attack on the proto-oncogenes, and thus it may be entirely reversible. Epigenetic processes of hypermethylation of the genes at the promoters of tumor suppressor genes (to silence them), and deacetylation of the histones aimed at the promoters of proto-oncogenes (to activate them) are on-going. A large number of short RNA sequences (interfering, micro-, short hairpin, non-coding RNAs) silence tumor suppressor genes, by neutralizing their mRNAs. In a serial sequence oncogenes undergo amplifications, point-mutations, translocations and fusions. In its earliest stage, the process is reversible by demethylation of the silenced suppressor gene promoters (to reactivate them), or re-acetylation of the histones of the oncogene promoters, thus de-activating them. The external administration of histone deacetylase inhibitors usually leads to the restoration of histone acetylation. In time, the uncorrected processes solidify into constitutive and irreversible gene mutations. Some of the pathogens inducing inflammations with consquential malignant transformation contain oncogenic gene sequences (papilloma viruses, Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, hepatitis B and C viruses, Merkel cell polyoma virus, Helicobacter pylori, enterotoxigenic Bacteroides fragilis). These induced malignancies may be multifocal. Other pathogens are devoid of any known oncogenic genomic sequences (mycoplasma vav-carcinogenesis, chlamydia MALT-lymphoma genesis). In these cases the host's inflammatory reactions induce the malignant transformation in serial sequences of gene alterations initiated by hypoxia and reactive oxygen and nitrogen species generation. Carcinogenic intrinsic inflammatory processes endogenously initiated without a pathogen are recognized. Chronic inflammatory processes signal the RNA/DNA complex. In response, the DNA may revert into its ancient primordial 'immortal' format, which the clinics recognize as 'oncogenesis'. The DNA remains the ultimate master of bioengineering in order to sustain life. A discussion on the most versatile and resistant primordial RNA/DNA complex and the pre-, proto-, and unicellular world in which they co-existed is included.
Similar articles
-
The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.Mol Aspects Med. 2010 Apr;31(2):145-70. doi: 10.1016/j.mam.2010.02.008. Epub 2010 Mar 2. Mol Aspects Med. 2010. PMID: 20206201 Review.
-
Epigenetic changes in cancer.APMIS. 2007 Oct;115(10):1039-59. doi: 10.1111/j.1600-0463.2007.apm_636.xml.x. APMIS. 2007. PMID: 18042143 Review.
-
Oncogenes and human neoplasia.Clin Lab Med. 1986 Mar;6(1):167-79. Clin Lab Med. 1986. PMID: 3514096 Review.
-
Oncogenes and tumor suppressor genes as paradigms in oncogenesis.J BUON. 2007 Sep;12 Suppl 1:S9-12. J BUON. 2007. PMID: 17935284 Review.
-
[Generalities about carcinogenesis].C R Biol. 2008 Feb;331(2):114-25. doi: 10.1016/j.crvi.2007.03.003. Epub 2007 Apr 16. C R Biol. 2008. PMID: 18241804 French.
Cited by
-
Up-regulation of Ago2 expression in gastric carcinoma.Med Oncol. 2013;30(3):628. doi: 10.1007/s12032-013-0628-2. Epub 2013 Jun 18. Med Oncol. 2013. PMID: 23775134
-
The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review).Int J Oncol. 2015 Oct;47(4):1211-29. doi: 10.3892/ijo.2015.3102. Epub 2015 Jul 23. Int J Oncol. 2015. PMID: 26239915 Free PMC article. Review.
-
A novel microRNA miR-4433a-3p as a potential diagnostic biomarker for lung adenocarcinoma.Heliyon. 2024 May 4;10(9):e30646. doi: 10.1016/j.heliyon.2024.e30646. eCollection 2024 May 15. Heliyon. 2024. PMID: 38765119 Free PMC article.
-
Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.Transl Res. 2013 Aug;162(2):77-92. doi: 10.1016/j.trsl.2013.03.004. Epub 2013 Apr 6. Transl Res. 2013. PMID: 23567332 Free PMC article. Review.
-
Cancer invasion and anaerobic bacteria: new insights into mechanisms.J Med Microbiol. 2024 Mar;73(3):001817. doi: 10.1099/jmm.0.001817. J Med Microbiol. 2024. PMID: 38535967 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous